Literature DB >> 22079341

Investigation of the mechanisms of progesterone protection following oxygen-glucose deprivation in organotypic hippocampal slice cultures.

Elizabeth Radley1, Asha Akram, Blair D Grubb, Claire L Gibson.   

Abstract

This study aimed to test the hypothesis that progesterone is neuroprotective against oxygen-glucose deprivation (OGD) through its conversion to the active metabolite allopregnanolone (AlloP) and the potentiation of GABA(A) receptors. Organotypic hippocampal cultures were exposed to 2h of OGD and the resulting cell death was quantified 24h later using combined propidium iodide and Hoechst immunostaining. Initially, we confirmed, that both progesterone and AlloP were protective in terms of reducing cell death following OGD in hippocampal cultures and for both, the optimal level of protection was observed at a concentration of 0.1μM. However, the protective effect of progesterone was absent in the presence of finasteride (10μM) which inhibits the metabolism of progesterone to active metabolites, including AlloP. In addition, the concurrent application of picrotoxin (100μM), a potent GABA(A) receptor antagonist, prevented the protection previously seen by either progesterone or AlloP alone. These results indicate that progesterone protects hippocampal cultures from cell death following OGD largely due to its conversion to AlloP and that GABA(A) receptors are important mediators of the protective effects of both progesterone and AlloP.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079341     DOI: 10.1016/j.neulet.2011.10.065

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Design and synthesis of neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapy.

Authors:  Zhihui Qin; Jia Luo; Lawren VandeVrede; Ehsan Tavassoli; Mauro Fa'; Andrew F Teich; Ottavio Arancio; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2012-07-24       Impact factor: 7.446

2.  Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.

Authors:  Christine E Marx; Jimmy Lee; Mythily Subramaniam; Attilio Rapisarda; Dianne C T Bautista; Edwin Chan; Jason D Kilts; Robert W Buchanan; Eu Pui Wai; Swapna Verma; Kang Sim; Jayaraman Hariram; Rajesh Jacob; Richard S E Keefe; Siow Ann Chong
Journal:  Psychopharmacology (Berl)       Date:  2014-07-17       Impact factor: 4.530

3.  Combination of mild hypothermia with neuroprotectants has greater neuroprotective effects during oxygen-glucose deprivation and reoxygenation-mediated neuronal injury.

Authors:  Xiao-Ya Gao; Jian-Ou Huang; Ya-Fang Hu; Yong Gu; Shu-Zhen Zhu; Kai-Bin Huang; Jin-Yu Chen; Su-Yue Pan
Journal:  Sci Rep       Date:  2014-11-18       Impact factor: 4.379

4.  Establishment of mouse neuron and microglial cell co-cultured models and its action mechanism.

Authors:  Bo Zhang; Yunfeng Yang; Jun Tang; Yihao Tao; Bing Jiang; Zhi Chen; Hua Feng; Liming Yang; Gang Zhu
Journal:  Oncotarget       Date:  2017-06-27

5.  Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury.

Authors:  Raeed Altaee; Claire L Gibson
Journal:  BMC Neurosci       Date:  2020-01-29       Impact factor: 3.288

6.  Neuritogenic and neuroprotective effects of polar steroids from the Far East starfishes Patiria pectinifera and Distolasterias nipon.

Authors:  Natalia V Palyanova; Tatyana M Pankova; Marina V Starostina; Alla A Kicha; Natalia V Ivanchina; Valentin A Stonik
Journal:  Mar Drugs       Date:  2013-05-03       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.